A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours
Clinical trial NCT04949425 · TERMINATED
Trial details
- NCT number
- NCT04949425
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-13
- Primary completion
- 2022-04-21
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.